Synmosa Biopharma vs Bora: monthly revenue

Monthly revenue and year-on-year change for Synmosa Biopharma (4114) and Bora (6472) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Synmosa Biopharma ━ Bora

0%+60%-30%25/1026/0126/0426/0726/10

Monthly revenue history

MonthSynmosa BiopharmaYoYBoraYoY
Oct 2026NT$766.6 million+41.2%NT$1.99 billion+15.9%
Sep 2026NT$747 million+38.7%NT$2.33 billion+35.1%
Aug 2026NT$754.3 million+49.9%NT$2.18 billion+59.2%
Jul 2026NT$791.7 million+59.8%NT$1.9 billion+5.8%
Jun 2026NT$750.9 million+30.7%NT$2.3 billion+39.2%
May 2026NT$600.8 million+12.9%NT$2.11 billion+40.2%
Apr 2026NT$570.4 million+13.5%NT$1.48 billion-27.5%
Mar 2026NT$562.6 million+17.3%NT$1.53 billion+6.3%
Feb 2026NT$430.3 million-7.8%NT$1.33 billion-23.2%
Jan 2026NT$634.9 million+25.4%NT$1.14 billion-30.2%
Dec 2025NT$543.7 million+4.3%NT$1.66 billion-16.6%
Nov 2025NT$502.6 million+0.9%NT$1.5 billion-10.8%
Oct 2025NT$543 million+9.2%NT$1.72 billion-17.8%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16